The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli

scientific article

The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1093/INFDIS/151.5.775
P698PubMed publication ID3886804
P5875ResearchGate publication ID19274744

P2093author name stringLior H
Arbus GS
Karmali MA
Petric M
Fleming PC
Lim C
P433issue5
P407language of work or nameEnglishQ1860
P921main subjectEscherichia coliQ25419
P1104number of pages8
P304page(s)775-782
P577publication date1985-05-01
P1433published inJournal of Infectious DiseasesQ4051141
P1476titleThe association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli
P478volume151

Reverse relations

cites work (P2860)
Q37091677A Novel Shiga Toxin 1a-Converting Bacteriophage of Shigella sonnei With Close Relationship to Shiga Toxin 2-Converting Pages of Escherichia coli
Q39799605A PCR-based assay for the detection of Escherichia coli Shiga-like toxin genes in ground beef
Q42585716A case-control study of selected pathogens including verocytotoxigenic Escherichia coli in calf diarrhea on an Ontario veal farm
Q33371578A classification of hemolytic uremic syndrome and thrombotic thrombocytopenic purpura and related disorders
Q33384189A dietary non-human sialic acid may facilitate hemolytic-uremic syndrome
Q33447751A family outbreak of hemolytic-uremic syndrome associated with verotoxin-producing Escherichia coli serotype O157:H7.
Q47108133A hemolytic-uremic syndrome-associated strain O113:H21 Shiga toxin-producing Escherichia coli specifically expresses a transcriptional module containing dicA and is related to gene network dysregulation in Caco-2 cells
Q42124163A longitudinal study of Vero cytotoxin producing Escherichia coli in cattle calves in Sri Lanka
Q39871476A multi-level approach for investigating socio-economic and agricultural risk factors associated with rates of reported cases of Escherichia coli O157 in humans in Alberta, Canada
Q27622010A mutant Shiga-like toxin IIe bound to its receptor Gb(3): structure of a group II Shiga-like toxin with altered binding specificity
Q38294429A mutational analysis of the globotriaosylceramide-binding sites of verotoxin VT1.
Q44245678A novel caspase dependent pathway is involved in apoptosis of human endothelial cells by Shiga toxins
Q35125841A novel mechanism of bacterial toxin transfer within host blood cell-derived microvesicles
Q37016559A plasmid of enterohemorrhagic Escherichia coli O157:H7 is required for expression of a new fimbrial antigen and for adhesion to epithelial cells
Q33494314A prospective study of exposure to verotoxin-producing Escherichia coli among Canadian children with haemolytic uraemic syndrome. The CPKDRC co-investigators
Q33427445A rapid and sensitive method to measure the functional activity of Shiga toxins in human serum
Q33997875A reverse-sandwich enzyme-linked immunosorbent assay for verocytotoxin 1 and 2 antibodies in human and bovine sera
Q33410645A single VHH-based toxin-neutralizing agent and an effector antibody protect mice against challenge with Shiga toxins 1 and 2.
Q42254722A stochastic model for transmission, extinction and outbreak of Escherichia coli O157:H7 in cattle as affected by ambient temperature and cleaning practices.
Q34065066A therapeutic agent with oriented carbohydrates for treatment of infections by Shiga toxin-producing Escherichia coli O157:H7.
Q33401658A time for reappraisal of "atypical" hemolytic uremic syndrome: should all patients be treated the same?
Q33418645ADAMTS-13 in the Diagnosis and Management of Thrombotic Microangiopathies
Q34922868Action of shiga toxin type-2 and subtilase cytotoxin on human microvascular endothelial cells
Q31948409Activation of the caspase cascade during Stx1-induced apoptosis in Burkitt's lymphoma cells
Q33488517Acute renal failure associated withCandida albicans infection
Q33498942Acute renal failure due to hemolytic uremic syndrome in adult patients
Q33385402Acute renal failure in a female adolescent with leukemia in remission
Q35109009Acute renal tubular necrosis and death of mice orally infected with Escherichia coli strains that produce Shiga-like toxin type II
Q40937562Adaptation of Escherichia coli O157:H7 to pH alters membrane lipid composition, verotoxin secretion, and resistance to simulated gastric fluid acid
Q40146295Adherence of enterohemorrhagic Escherichia coli strains to a human colonic epithelial cell line (T84).
Q33376471Adult hemolytic-uremic syndrome associated with urosepsis due to Shigatoxin-producing Escherichia coli O138:H-.
Q36997934Affinity purification and characterization of Shiga-like toxin II and production of toxin-specific monoclonal antibodies
Q36068651Affinity-Based Screening of Tetravalent Peptides Identifies Subtype-Selective Neutralizers of Shiga Toxin 2d, a Highly Virulent Subtype, by Targeting a Unique Amino Acid Involved in Its Receptor Recognition
Q39341582Age-Related Changes of Serum Soluble Interleukin 9 Receptor (sIL-9Rα) in Healthy Subjects
Q33380037Age-dependent decrease in serum soluble interferon-gamma receptor (sIFN-gammaR) in healthy Japanese individuals; population study of serum sIFN-gammaR level in Japanese
Q73409149Alpha-galactose based neoglycopeptides. Inhibition of verotoxin binding to globotriosylceramide
Q36785336Alteration of the carbohydrate binding specificity of verotoxins from Gal alpha 1-4Gal to GalNAc beta 1-3Gal alpha 1-4Gal and vice versa by site-directed mutagenesis of the binding subunit
Q42941754Alteration of the glycolipid binding specificity of the pig edema toxin from globotetraosyl to globotriaosyl ceramide alters in vivo tissue targetting and results in a verotoxin 1-like disease in pigs
Q33488951Altered renovascular resistance after spontaneous recovery from hemolytic uremic syndrome
Q36957798An enzymatic mutant of Shiga-like toxin II variant is a vaccine candidate for edema disease of swine
Q39894763An enzyme-linked immunosorbent assay-based isolation procedure for verotoxigenic Escherichia coli.
Q54523532An epidemiological study on Verotoxin-producing Escherichia coli (VTEC) infection among population of northern region of Iran (Mazandaran and Golestan provinces).
Q42947533An orally applicable Shiga toxin neutralizer functions in the intestine to inhibit the intracellular transport of the toxin.
Q54442932An outbreak of Escherichia coli O157:H7 infection in southern Sweden associated with consumption of fermented sausage; aspects of sausage production that increase the risk of contamination.
Q33504966An unusual case of microangiopathic haemolytic anaemia associated with enterohaemorrhagic Escherichia coli O113:H21 infection, a verocytotoxin-2/shiga toxin-2 producing serotype
Q33719498Analysis of Escherichia coli O157:H7 survival in ovine or bovine manure and manure slurry.
Q54355968Antibodies anti-Shiga toxin 2 B subunit from chicken egg yolk: isolation, purification and neutralization efficacy.
Q33429198Antibodies to Escherichia coli O157 in patients with haemorrhagic colitis and haemolytic uraemic syndrome
Q40186741Antibodies to shiga holotoxin and to two synthetic peptides of the B subunit in sera of patients with Shigella dysenteriae 1 dysentery
Q33337454Antibody response to Shiga toxins Stx2 and Stx1 in children with enteropathic hemolytic-uremic syndrome
Q33877305Antibody-based protection of gnotobiotic piglets infected with Escherichia coli O157:H7 against systemic complications associated with Shiga toxin 2.
Q33445938Anticytotoxin-neutralizing antibodies in immune globulin preparations: potential use in hemolytic-uremic syndrome
Q42126833Antidiarrheal Agents: More to the Apple Sauce Than You Might Think: Treating infectious diarrheas.
Q44354606Antigenic heterogeneity of Escherichia coli verotoxins
Q33501527Apoptosis of renal cortical cells in the hemolytic-uremic syndrome: in vivo and in vitro studies
Q33496262Are there restrictions to vaccinating a child who has recovered from hemolytic uremic syndrome?
Q33374555Association between severity of gastrointestinal prodrome and long-term prognosis in classic hemolytic-uremic syndrome
Q37058874Association of genomic O island 122 of Escherichia coli EDL 933 with verocytotoxin-producing Escherichia coli seropathotypes that are linked to epidemic and/or serious disease
Q40157780Attaching and effacing adherence of Vero cytotoxin-producing Escherichia coli to rabbit intestinal epithelium in vivo
Q33494589Atypical (non-diarrhea-associated) hemolytic-uremic syndrome in childhood
Q33337686BMT: Bone Marrow Transplant Associated Thrombotic Microangiopathy
Q40160063Bacterial endotoxin both enhances and inhibits the toxicity of Shiga-like toxin II in rabbits and mice
Q39627920Bacterial gastroenteritis.
Q39567179Bacterial-induced diarrhoea
Q38519709Binding of shiga toxin 2e to porcine erythrocytes in vivo and in vitro
Q38718403Biofilm formation, invasiveness and colicinogeny in locus of enterocyte and effacement negative O113:H21 Shigatoxigenic Escherichia coli
Q57528836Bioinspired Functionalized Nanoparticles as Tools for Detection, Quantification and Targeting of Biomolecules
Q38936714Biological roles of glycans
Q35026634Bovine non-O157 Shiga toxin 2-containing Escherichia coli isolates commonly possess stx2-EDL933 and/or stx2vhb subtypes
Q43476342Bovine reservoir for verotoxin-producing Escherichia coli O157:H7.
Q48192053Brainstem mechanisms of autonomic dysfunction in encephalopathy-associated Shiga toxin 2 intoxication
Q41996638British Escherichia coli O157 in Cattle Study (BECS): to determine the prevalence of E. coli O157 in herds with cattle destined for the food chain.
Q40847307CD40 ligand, Bcl-2, and Bcl-xL spare group I Burkitt lymphoma cells from CD77-directed killing via Verotoxin-1 B chain but fail to protect against the holotoxin
Q36503520Cattle as a possible source of verocytotoxin-producing Escherichia coli O157 infections in man.
Q54763061Cattle as reservoir of verotoxin-producing Escherichia coli O157:H7.
Q33415947Causes of the haemolytic uraemic syndrome
Q33396647Change in conformation with reduction of alpha-helix content causes loss of neutrophil binding activity in fully cytotoxic Shiga toxin 1.
Q38341459Characteristics of binding of Escherichia coli serotype O157:H7 strain CL-49 to purified intestinal mucin
Q42574372Characteristics of verotoxigenic Escherichia coli from pigs
Q40332508Characterization and Virulence Potential of Serogroup O113 Shiga Toxin-Producing Escherichia coli Strains Isolated from Beef and Cattle in the United States.
Q40724731Characterization and evidence of mobilization of the LEE pathogenicity island of rabbit-specific strains of enteropathogenic Escherichia coli
Q37156215Characterization of Escherichia coli serotype O157:H7.
Q33553290Characterization of Saa, a novel autoagglutinating adhesin produced by locus of enterocyte effacement-negative Shiga-toxigenic Escherichia coli strains that are virulent for humans
Q36818691Characterization of Shiga Toxin Subtypes and Virulence Genes in Porcine Shiga Toxin-Producing Escherichia coli
Q42859529Characterization of Shiga-like toxin I B subunit purified from overproducing clones of the SLT-I B cistron
Q33884882Characterization of a shiga toxin-, intimin-, and enterotoxin hemolysin-producing Escherichia coli ONT:H25 strain commonly isolated from healthy cattle
Q39823954Characterization of an RTX toxin from enterohemorrhagic Escherichia coli O157:H7.
Q37151695Characterization of flagella purified from enterohemorrhagic, vero-cytotoxin-producing Escherichia coli serotype O157:H7.
Q33328717Characterization of the baboon responses to Shiga-like toxin: descriptive study of a new primate model of toxic responses to Stx-1
Q41918220Chemokine expression in human astrocytes in response to shiga toxin 2
Q33372575Childhood hemolytic uremic syndrome is associated with adolescent-onset diabetes mellitus
Q33370432Chromosomal dynamism in progeny of outbreak-related sorbitol-fermenting enterohemorrhagic Escherichia coli O157:NM.
Q33412570Chronic sequelae of E. coli O157: systematic review and meta-analysis of the proportion of E. coli O157 cases that develop chronic sequelae
Q33345355Circulating granulocyte colony-stimulating factor, C-X-C, and C-C chemokines in children with Escherichia coli O157:H7 associated hemolytic uremic syndrome
Q33331088Circulating levels of transforming growth factor-beta1 and lymphokines among children with hemolytic uremic syndrome
Q33491119Cisplatin-associated hemolytic uremic syndrome
Q27306436Clade 8 and Clade 6 Strains of Escherichia coli O157:H7 from Cattle in Argentina have Hypervirulent-Like Phenotypes
Q37336265Clinical evaluation of a real-time PCR assay for identification of Salmonella, Shigella, Campylobacter (Campylobacter jejuni and C. coli), and shiga toxin-producing Escherichia coli isolates in stool specimens.
Q33385986Clinical practice. Today's understanding of the haemolytic uraemic syndrome
Q54651961Clinical signs and lesions in gnotobiotic pigs inoculated with Shiga-like toxin I from Escherichia coli.
Q33424960Clinical-Pathological Conference Series from the Medical University of Graz Case No 155: 26-year-old woman in third trimester of pregnancy with epigastric pain and thrombocytopenia
Q39965419Cloning and expression of the genes specifying Shiga-like toxin production in Escherichia coli H19.
Q68090249Cloning and sequencing of a Shiga-like toxin II-related gene from Escherichia coli O157:H7 strain 7279
Q36194407Cloning and sequencing of the genes for Shiga toxin from Shigella dysenteriae type 1.
Q37007761Cloning of genes for production of Escherichia coli Shiga-like toxin type II
Q37162735Close association of verotoxin (Shiga-like toxin) production with enterohemolysin production in strains of Escherichia coli
Q35042338Commensal E. coli Stx2 lysogens produce high levels of phages after spontaneous prophage induction
Q36060108Comparative Characterization of Shiga Toxin Type 2 and Subtilase Cytotoxin Effects on Human Renal Epithelial and Endothelial Cells Grown in Monolayer and Bilayer Conditions
Q58588700Comparative Genomics and Characterization of the Late Promoter R' from Shiga Toxin Prophages in
Q59391030Comparative Genomics and Characterization of the Late Promoter pR’ from Shiga Toxin Prophages in Escherichia coli
Q77390584Comparison of 14 PCR systems for the detection and subtyping of stx genes in Shiga-toxin-producing Escherichia coli
Q33947074Comparison of Shiga toxin-producing Escherichia coli detection methods using clinical stool samples
Q40133558Comparison of a Shiga Toxin Enzyme-Linked Immunosorbent Assay and Two Types of PCR for Detection of Shiga Toxin-Producing Escherichia coli in Human Stool Specimens
Q37116299Comparison of a direct fecal Shiga-like toxin assay and sorbitol-MacConkey agar culture for laboratory diagnosis of enterohemorrhagic Escherichia coli infection
Q41896763Comparison of clinical and epidemiological features of Shiga toxin-producing Escherichia coli O157 and non-O157 infections in British Columbia, 2009 to 2011.
Q54567409Comparison of ribosome-inactivating proteins in the induction of apoptosis.
Q36977977Comparison of the glycolipid receptor specificities of Shiga-like toxin type II and Shiga-like toxin type II variants
Q33498518Comparison of the western blot assay with the neutralizing-antibody and enzyme-linked immunosorbent assays for measuring antibody to verocytotoxin 1.
Q33404523Comparison of three different methods for detection of Shiga toxin-producing Escherichia coli in a tertiary pediatric care center
Q35132357Comparisons of native Shiga toxins (Stxs) type 1 and 2 with chimeric toxins indicate that the source of the binding subunit dictates degree of toxicity
Q33654317Complete Genome Sequences of Two Escherichia coli O145:H28 Outbreak Strains of Food Origin.
Q33406356Comprehensive analysis of glomerular mRNA expression of pro- and antithrombotic genes in atypical haemolytic-uremic syndrome (aHUS).
Q33494319Concentrations of interleukin 6 and tumour necrosis factor in serum and stools of children with Shigella dysenteriae 1 infection.
Q43254870Conditioned medium from enterohemorrhagic Escherichia coli-infected T84 cells inhibits signal transducer and activator of transcription 1 activation by gamma interferon
Q92627201Consensus regarding diagnosis and management of atypical hemolytic uremic syndrome
Q36633507Contemporary issues: diseases with a food vector
Q35220329Contribution of FliC to epithelial cell invasion by enterohemorrhagic Escherichia coli O113:H21.
Q34358725Correlation between in vivo biofilm formation and virulence gene expression in Escherichia coli O104:H4.
Q35102179Correlation of enterohemorrhagic Escherichia coli O157 prevalence in feces, hides, and carcasses of beef cattle during processing
Q35075768Cross-reactive protection against enterohemorrhagic Escherichia coli infection by enteropathogenic E. coli in a mouse model
Q33396586Culture confirmation of Escherichia coli serotype O157:H7 by direct immunofluorescence
Q42978314Culture negative cytotoxin positive stools in community acquired diarrhoea
Q33346852Current concepts in the diagnosis and management of thrombotic thrombocytopenic purpura
Q27003211Current treatment of atypical hemolytic uremic syndrome
Q33375457Current views on aetiology and management of haemolytic uraemic syndrome
Q40282722Cytocompatibility and antibacterial activity of a PHBV membrane with surface-immobilized water-soluble chitosan and chondroitin-6-sulfate
Q33399069Cytokine production is altered in monocytes from children with hemolytic uremic syndrome
Q37020358Cytotoxicity of Shiga toxin for primary cultures of human colonic and ileal epithelial cells
Q37151311DNA probes for Shiga-like toxins I and II and for toxin-converting bacteriophages
Q40195165DNA probes to identify Shiga-like toxin I- and II-producing enteric bacterial pathogens isolated from patients with diarrhea in Thailand
Q33329124Depletion of liver and splenic macrophages reduces the lethality of Shiga toxin-2 in a mouse model
Q40174976Detection and characterization of the eae gene of Shiga-like toxin-producing Escherichia coli using polymerase chain reaction
Q38847624Detection and prevalence of verotoxin-producing Escherichia coli O157 and non-O157 serotypes in a Canadian watershed
Q33336219Detection of apoptosis in kidney biopsies of patients with D+ hemolytic uremic syndrome.
Q33494833Detection of verocytotoxin from stool and serological testing of patients with diarrhea caused by Escherichia coli O157 : H7.
Q33410450Detection of verotoxin in stool specimens
Q47880128Detection of verotoxin-producing Escherichia coli O157:H7 by multiplex polymerase chain reaction
Q37168692Determination by DNA hybridization of Shiga-like-toxin-producing Escherichia coli in children with diarrhea in Thailand
Q39773693Determination of soluble tumor necrosis factor-α receptor type I (TNFRI) and II (TNFRII) in the urine of healthy Japanese subjects
Q99636418Determining the long-term health burden and risk of sequelae for 14 foodborne infections in British Columbia, Canada: protocol for a retrospective population-based cohort study
Q92783425Development and Validation of Shiga Toxin-Producing Escherichia coli Immunodiagnostic Assay
Q40199718Development and evaluation of enzyme-linked immunosorbent assays for detection of shiga-like toxin I and shiga-like toxin II.
Q28534818Dexamethasone rescues neurovascular unit integrity from cell damage caused by systemic administration of shiga toxin 2 and lipopolysaccharide in mice motor cortex
Q24533466Diarrheagenic Escherichia coli
Q39051292Diarrhoea caused byEscherichia coli
Q42273167Differences in Shiga toxin and phage production among stx(2g)-positive STEC strains
Q54658182Differences in verotoxin neutralizing activity of therapeutic immunoglobulins and sera from healthy controls.
Q33367484Differential expression of function-related antigens on blood monocytes in children with hemolytic uremic syndrome
Q40312938Differential virulence of clinical and bovine-biased enterohemorrhagic Escherichia coli O157:H7 genotypes in piglet and Dutch belted rabbit models
Q33415795Direct acute tubular damage contributes to Shigatoxin-mediated kidney failure
Q36999010Direct cytotoxic action of Shiga toxin on human vascular endothelial cells
Q50135970Direct detection by PCR of Escherichia coli O157 and enteropathogens in patients with bloody diarrhea
Q33963092Direct detection of Shiga toxigenic Escherichia coli strains belonging to serogroups O111, O157, and O113 by multiplex PCR.
Q36519199Direct detection of verotoxin-producing Escherichia coli in stool samples by PCR.
Q34534278Direct evidence of neuron impairment by oral infection with verotoxin-producing Escherichia coli O157:H- in mitomycin-treated mice.
Q54296415Discovery of inhibitors of Shiga toxin type 2 by on-plate generation and screening of a focused compound library.
Q33406110Disseminated prostatic carcinoma presenting with acute interstitial nephritis and microangiopathic haemolytic anaemia
Q40374985Distinct binding properties of eaeA-negative verocytotoxin-producing Escherichia coli of serotype O113:H21.
Q33388849Distinct physiologic and inflammatory responses elicited in baboons after challenge with Shiga toxin type 1 or 2 from enterohemorrhagic Escherichia coli
Q41997764Distribution of Gb(3) Immunoreactivity in the Mouse Central Nervous System
Q39570787Divergent signal transduction responses to infection with attaching and effacing Escherichia coli.
Q35573487Diversity of Shiga Toxin-Producing Escherichia coli (STEC) O26:H11 Strains Examined via stx Subtypes and Insertion Sites of Stx and EspK Bacteriophages.
Q45949070Draft Genome Sequences of Escherichia coli O113:H21 Strains Recovered from a Major Produce Production Region in California.
Q91747714Dynamic Gene Network Analysis of Caco-2 Cell Response to Shiga Toxin-Producing Escherichia coli-Associated Hemolytic-Uremic Syndrome
Q40426879Edema disease-like brain lesions in gnotobiotic piglets infected with Escherichia coli serotype O157:H7
Q42486029Effect of Shiga toxin 2 on water and ion transport in human colon in vitro
Q33337469Effect of Shiga toxin and Shiga-like toxins on eukaryotic cells
Q33849613Effect of shiga toxin and its subunits on cytokine induction in different cell lines
Q33364452Effect of subinhibitory concentrations of antibiotics on extracellular Shiga-like toxin I.
Q53946808Effect of subtherapeutic concentrations of tylosin on the inhibitory stringency of a mixed anaerobe continuous-flow culture of chicken microflora against Escherichia coli O157:H7.
Q41771592Effect of the Food Additives Sodium Citrate and Disodium Phosphate on Shiga Toxin-Producing Escherichia coli and Production of stx-Phages and Shiga toxin
Q33330389Effectiveness of therapeutic plasma exchange in the 1996 Lanarkshire Escherichia coli O157:H7 outbreak
Q41763522Effects of Escherichia coli subtilase cytotoxin and Shiga toxin 2 on primary cultures of human renal tubular epithelial cells
Q26777059Effects of Mycotoxins on mucosal microbial infection and related pathogenesis
Q34004015Effects of Shiga toxin 2 on lethality, fetuses, delivery, and puerperal behavior in pregnant mice
Q34889826Effects of Shiga toxin type 2 on a bioengineered three-dimensional model of human renal tissue
Q33498793Effects of TNF alpha on verocytotoxin cytotoxicity in purified human glomerular microvascular endothelial cells.
Q34142282Effects of azithromycin on shiga toxin production by Escherichia coli and subsequent host inflammatory response
Q37215545Effects of cycloheximide and puromycin on cytotoxic activity of Escherichia coli verocytotoxin (Shiga-like toxin).
Q54302067Efficacy of recombinant human soluble thrombomodulin for childhood hemolytic uremic syndrome.
Q39482675Electrophoretic mobilities of Escherichia coli O157:H7 and wild-type Escherichia coli strains.
Q33360774Elevated levels of vascular endothelial growth factor in serum of patients with D+ HUS.
Q39093646Emerging Public Health Challenges of Shiga Toxin-Producing Escherichia coli Related to Changes in the Pathogen, the Population, and the Environment
Q41575546Endocytosis from coated pits of Shiga toxin: a glycolipid-binding protein from Shigella dysenteriae 1.
Q33346344Endogenous glucocorticoids attenuate Shiga toxin-2-induced toxicity in a mouse model of haemolytic uraemic syndrome
Q43110447Endothelial Dysfunction: The Secret Agent Driving Kidney Disease
Q33389052Endothelial damage induced by Shiga toxins delivered by neutrophils during transmigration
Q33752654Enhancement of susceptibility to Shiga toxin-producing Escherichia coli O157:H7 by protein calorie malnutrition in mice
Q43086295Enterohaemorrhagic Escherichia coli O157:H7 target Peyer's patches in humans and cause attaching/effacing lesions in both human and bovine intestine
Q33379683Enterohaemorrhagic Escherichia coli and Shigella dysenteriae type 1-induced haemolytic uraemic syndrome
Q43422802Enterohaemorrhagic Escherichia coli serotype O157:H7 as an enteric pathogen in Irish children
Q33497368Enterohemolytic phenotypes and genotypes of shiga toxin-producing Escherichia coli O111 strains from patients with diarrhea and hemolytic-uremic syndrome
Q33402961Enterohemorrhagic E. coli (EHEC) pathogenesis
Q33359877Enterohemorrhagic Escherichia coli associated with hemolytic-uremic syndrome in Chilean children
Q38926009Enterohemorrhagic Escherichia coli colonization of human colonic epithelium in vitro and ex vivo
Q39515881Enterohemorrhagic Escherichia coli induces apoptosis which augments bacterial binding and phosphatidylethanolamine exposure on the plasma membrane outer leaflet.
Q50172861EnterohemorrhagicEscherichia coli O157:H7 possesses somatic (O) antigen identical with that ofSalmonella O301
Q33492004Enzyme-linked immunosorbent assay for detection of immunoglobulin G antibodies to Escherichia coli Vero cytotoxin 1
Q33501155Epidemic hemolytic-uremic syndrome in children
Q33329451Epidemiology and diagnosis of Shiga toxin-producing Escherichia coli infections.
Q33495990Epidemiology of infection due to Escherichia coli O157: a 3-year prospective study
Q73207396Epigallocatechin gallate and gallocatechin gallate in green tea catechins inhibit extracellular release of Vero toxin from enterohemorrhagic Escherichia coli O157:H7
Q33377324Escherichia Coli O157: H7, a Cause of Hemorrhagic Colitis and Hemolytic Uremic Syndrome
Q33343335Escherichia coli 'O' group serological responses and clinical correlations in epidemic HUS patients
Q37287149Escherichia coli O157:H7 Strain EDL933 Harbors Multiple Functional Prophage-Associated Genes Necessary for the Utilization of 5-N-Acetyl-9-O-Acetyl Neuraminic Acid as a Growth Substrate
Q33330315Escherichia coli O157:H7 and O157:H(-) strains that do not produce Shiga toxin: phenotypic and genetic characterization of isolates associated with diarrhea and hemolytic-uremic syndrome.
Q68929313Escherichia coli O157:H7 infections associated with perforated appendicitis and chronic diarrhoea
Q33498630Escherichia coli O157:H7--two case reports
Q33394010Escherichia coli Shiga Toxin Mechanisms of Action in Renal Disease
Q24604606Escherichia coli Subtilase Cytotoxin
Q36250303Escherichia coli diarrhoea
Q41476186Escherichia coli from Crohn's disease patient displays virulence features of enteroinvasive (EIEC), enterohemorragic (EHEC), and enteroaggregative (EAEC) pathotypes
Q68927490Escherichia coli gastroenteritis: making sense of the new acronyms. Infectious Diseases and Immunization Committee, Canadian Paediatric Society
Q40349623Escherichia coli verotoxin 1 mediates apoptosis in human HCT116 colon cancer cells by inducing overexpression of the GADD family of genes and S phase arrest
Q54598931Escherichia coli verotoxin binding to human paediatric glomerular mesangial cells.
Q33488736Escherichia coliO157:H7 and the Hemolytic–Uremic Syndrome
Q37676422Etiology and mechanisms of acute infectious diarrhea in infants in the United States
Q37229195Etiology of childhood diarrhea in Beijing, China
Q40199630Etiology of childhood diarrhea in Korea
Q39446323Evaluation of a microplate latex agglutination method (Verotox-F assay) for detecting and characterizing verotoxins (Shiga toxins) in Escherichia coli
Q40006733Evaluation of an immunoassay for direct detection of Escherichia coli O157 in stool specimens
Q36533106Evaluation of commercial latex reagents for identification of O157 and H7 antigens of Escherichia coli
Q39629490Evaluation of commercial latex slide test for identifying Escherichia coli O157.
Q40199619Evaluation of oligonucleotide probes for identification of shiga-like-toxin-producing Escherichia coli
Q54405120Evaluation of three commercially available enzyme-linked immunosorbent assay kits for detection of Shiga toxin.
Q36575178Evidence for a hybrid genomic island in verocytotoxin-producing Escherichia coli CL3 (serotype O113:H21) containing segments of EDL933 (serotype O157:H7) O islands 122 and 48.
Q24651553Evidence that glutamic acid 167 is an active-site residue of Shiga-like toxin I
Q24633154Evidence that verotoxins (Shiga-like toxins) from Escherichia coli bind to P blood group antigens of human erythrocytes in vitro
Q64886207Exosome-associated Shiga toxin 2 is released from cells and causes severe toxicity in mice.
Q45174780Experimental Infection of Specific-Pathogen-Free Mice with EnterohemorrhagicEscherichia coli0157: H7
Q40165986Experimental infection of infant rabbits with verotoxin-producing Escherichia coli.
Q33353985Experimental verocytotoxemia in rabbits
Q40268887Expression and characterization of the eaeA gene product of Escherichia coli serotype O157:H7.
Q33493211Expression of A and B subunits of Shiga-like toxin II as fusions with glutathione S-transferase and their potential for use in seroepidemiology
Q36505072Extended phage-typing scheme for Escherichia coli O157:H7
Q33489626Extrarenal involvement in diarrhoea-associated haemolytic-uraemic syndrome
Q37142305Factors Associated with Shiga Toxin-Producing Escherichia coli Shedding by Dairy and Beef Cattle.
Q33353982Failure to isolate verotoxin producing Escherichia coli from patients of haemolytic uremic syndrome
Q37290075Fecal diagnostics in combination with serology: best test to establish STEC-HUS.
Q36472867First recognized community outbreak of haemorrhagic colitis due to verotoxin-producing Escherichia coli O 157.H7 in the UK.
Q41930818Focal segmental glomerulosclerosis associated with infantile spasms in five mentally retarded children: a morphological analysis on mesangiolysis
Q24633220Foodborne illness acquired in the United States--unspecified agents
Q40147730Frequent loss of Shiga-like toxin genes in clinical isolates of Escherichia coli upon subcultivation
Q51783645Genetic Analysis of Virulence Potential of Escherichia coli O104 Serotypes Isolated From Cattle Feces Using Whole Genome Sequencing.
Q92001002Genetic Diversity of Non-O157 Shiga Toxin-Producing Escherichia coli Recovered From Patients in Michigan and Connecticut
Q38991043Genetic and Mechanistic Analyses of the Periplasmic Domain of the Enterohemorrhagic Escherichia coli QseC Histidine Sensor Kinase.
Q42273128Genetic characteristics of Shiga toxin-producing E. coli O157, O26, O103, O111 and O145 isolates from humans, food, and cattle in Belgium.
Q34107040Genetic diversity and virulence potential of shiga toxin-producing Escherichia coli O113:H21 strains isolated from clinical, environmental, and food sources
Q36999232Genetic relationships among pathogenic Escherichia coli of serogroup O157
Q24624844Genome sequence analyses of two isolates from the recent Escherichia coli outbreak in Germany reveal the emergence of a new pathotype: Entero-Aggregative-Haemorrhagic Escherichia coli (EAHEC)
Q36845551Genomic O island 122, locus for enterocyte effacement, and the evolution of virulent verocytotoxin-producing Escherichia coli.
Q34114191Genomic subtraction to identify and characterize sequences of Shiga toxin-producing Escherichia coli O91:H21.
Q41341761Genotypic characterization and prevalence of virulence factors among Canadian Escherichia coli O157:H7 strains
Q33418419Globosides as key players in the pathophysiology of Shiga toxin-associated acute kidney failure and Fabry disease
Q33387236Globotriaosyl ceramide receptor function - where membrane structure and pathology intersect
Q38291919Globotriose-functionalized gold nanoparticles as multivalent probes for Shiga-like toxin
Q54385143Globotriosyl ceramide is specifically recognized by the Escherichia coli verocytotoxin 2.
Q37954161Glomerular fibrin deposition and removal
Q33495323Glomerular ultrastructural lesions of idiopathic cutaneous and renal glomerular vasculopathy of greyhounds
Q33330688Glycolipid receptors for verotoxin and Helicobacter pylori: role in pathology
Q34394719Gnotobiotic piglet infection model for evaluating the safe use of antibiotics against Escherichia coli O157:H7 infection
Q27026538HUS and TTP in Children
Q33389799Haemolytic anaemia after childhood Escherichia coli O 157 .H7 infection: are females at increased risk?
Q72797522Haemolytic anaemia in association with Escherichia coli O157 infection in two sisters
Q33449632Haemolytic uraemic syndrome associated with Salmonella dysentery
Q33447746Haemolytic uraemic syndrome associated with Yersinia enterocolitica infection
Q33447741Haemolytic uraemic syndrome associated with faecal cytotoxin and verotoxin neutralizing antibodies
Q33369703Haemolytic uraemic syndrome associated with interfamilial spread of E. coli O26:H11.
Q33447267Haemolytic uraemic syndrome in adults
Q33388780Haemolytic uraemic syndrome in the defined population of northeast of Scotland
Q33397726Haemolytic uraemic syndromes in the British Isles 1985-8: association with verocytotoxin producing Escherichia coli. Part 1: Clinical and epidemiological aspects
Q33397728Haemolytic uraemic syndromes in the British Isles, 1985-8: association with verocytotoxin producing Escherichia coli. Part 2: Microbiological aspects
Q33403923Haemolytic-uraemic syndrome as a sequela of diarrhoeal disease
Q33380619Haemolytic-uraemic syndrome associated with Aeromonas hydrophila enterocolitis
Q33489318Haemolytic-uraemic syndrome in childhood: surveillance and case-control studies in Italy. Italian HUS Study Group
Q33490805Haemolytic-uraemic syndrome in practice
Q42744252Haemorrhagic colitis and Escherichia coli O157--a pathogen unmasked
Q33370343Haemorrhagic colitis and haemolytic-uraemic syndrome: false positive reaction with a rotavirus latex agglutination test
Q42841506Haemorrhagic colitis: detection of verotoxin producing Escherichia coli O157 in a clinical microbiology laboratory
Q40208572HeLa cell adherence and cytotoxin production by enteropathogenic Escherichia coli isolated from infants with diarrhea in Thailand
Q39890859Heat adaptation alters Escherichia coli O157:H7 membrane lipid composition and verotoxin production
Q41033263Hemolytic disorders associated with cancer
Q33429497Hemolytic uraemic syndrome following Salmonella typhimurium enteritis
Q33453248Hemolytic uremic syndrome and diarrhea associated with Escherichia coli O157:H7 in a day care center
Q33408648Hemolytic uremic syndrome complicating Mycoplasma pneumoniae infection
Q33368494Hemolytic uremic syndrome due to Escherichia coli O157: H7 in a child with multiple infections
Q33359891Hemolytic uremic syndrome induced by lipopolysaccharide and Shiga-like toxin
Q24669689Hemolytic uremic syndrome-associated Shiga toxins promote endothelial-cell secretion and impair ADAMTS13 cleavage of unusually large von Willebrand factor multimers
Q37288569Hemolytic uremic syndrome: late renal injury and changing incidence-a single centre experience in Canada
Q33435426Hemolytic-uremic syndrome (HUS) in children at the University Hospital Center in Dakar: about four cases
Q33375240Hemolytic-uremic syndrome and myocardial dysfunction in a 9-month-old boy.
Q33396501Hemolytic-uremic syndrome during an outbreak of Escherichia coli O157:H7 infections in institutions for mentally retarded persons: clinical and epidemiologic observations
Q53159950Hemolytic-uremic syndrome: a population-based study in Washington, DC and Baltimore, Maryland.
Q68524105Hemorrhagic colitis and Escherichia coli O157:H7--identifying a messenger while pursuing the message
Q34726358Hemorrhagic colitis due to Escherichia coli O157:H7. A rare disease?
Q37812850Hepatobiliary Manifestations of Critically Ill and Postoperative Patients
Q33337448Heterogeneity of Shiga toxin-producing Escherichia coli strains isolated from hemolytic-uremic syndrome patients, cattle, and food samples in central France
Q33381234High incidence of serum antibodies to Escherichia coli O157 lipopolysaccharide in children with hemolytic-uremic syndrome
Q49960179High-Quality Complete Genome Sequences of Three Bovine Shiga Toxin-Producing Escherichia coli O177:H- (fliCH25) Isolates Harboring Virulent stx2 and Multiple Plasmids
Q33383017Host and pathogen determinants of verocytotoxin-producing Escherichia coli-associated hemolytic uremic syndrome
Q33942303How does Escherichia coli O157:H7 testing in meat compare with what we are seeing clinically?
Q33340641Human Stx2-specific monoclonal antibodies prevent systemic complications of Escherichia coli O157:H7 infection
Q39751395Identification and Characterization of a New Variant of Shiga Toxin 1 in Escherichia coli ONT:H19 of Bovine Origin
Q37158316Identification of Escherichia coli serotype O157 strains by using a monoclonal antibody
Q41749422Identification of O serotypes, genotypes, and virulotypes of Shiga toxin-producing Escherichia coli isolates, including non-O157 from beef cattle in Japan
Q33494321Identification of a clone of Escherichia coli O103:H2 as a potential agent of hemolytic-uremic syndrome in France
Q35534259Identification of a family of intimins common to Escherichia coli causing attaching-effacing lesions in rabbits, humans, and swine
Q34643412Identification of a peptide-based neutralizer that potently inhibits both Shiga toxins 1 and 2 by targeting specific receptor-binding regions
Q34933393Identification of a wide range of motifs inhibitory to shiga toxin by affinity-driven screening of customized divalent peptides synthesized on a membrane
Q33221148Identification of four fimbria-encoding genomic islands that are highly specific for verocytotoxin-producing Escherichia coli serotype O157 strains
Q39697637Identification, characterization, and distribution of a Shiga toxin 1 gene variant (stx(1c)) in Escherichia coli strains isolated from humans
Q35892930Immune response to verotoxin 1 and 2 in children with Escherichia coli O157:H7 hemorrhagic colitis and classic hemolytic uremic syndrome
Q33387170Immune thrombocytopenia in pregnancy
Q38504443Immuno-based detection of Shiga toxin-producing pathogenic Escherichia coli in food - A review on current approaches and potential strategies for optimization
Q40267335Immunocompromise in gnotobiotic pigs induced by verotoxin-producing Escherichia coli (O111:NM).
Q43774740Immunohistochemical detection of verotoxin receptors in nervous system
Q54377737Immunomodulating Activity of Lactobacillus paracasei subsp. paracasei NTU 101 in Enterohemorrhagic Escherichia coli O157H7-Infected Mice
Q36521591Impact of free verotoxin testing on epidemiology of diarrhea caused by verotoxin-producing Escherichia coli.
Q33492871Impaired antioxidant defense mechanisms in two children with hemolytic-uremic syndrome
Q33359241Impaired detection of faecal verocytotoxin in the presence of Clostridium difficile cytotoxin in patients with haemolytic uraemic syndrome
Q33366669Impaired neutrophils in children with the typical form of hemolytic uremic syndrome
Q37211202Improved biochemical screening procedure for small clinical laboratories for vero (Shiga-like)-toxin-producing strains of Escherichia coli O157:H7.
Q38323354In vitro assessment of a chemically synthesized Shiga toxin receptor analog attached to chromosorb P (Synsorb Pk) as a specific absorbing agent of Shiga toxin 1 and 2.
Q45096420In vitro bactericidal activity of antimicrobial agents against enterohaemorrhagic Escherichia coli
Q51375879Incidence and index of severity of hemolytic uremic syndrome in a 26 year period in Fukushima Prefecture, Japan.
Q33489027Incomplete hemolytic-uremic syndrome in Argentinean children with bloody diarrhea
Q54646115Increased globotriaosylceramide on plasma membranes of synchronized familial dysautonomia cells. Verotoxin binding studies.
Q33837961Induction of verotoxin sensitivity in receptor-deficient cell lines using the receptor glycolipid globotriosylceramide
Q33331859Infarction of the choledochus, liver, gallbladder, and pancreas: a unique complication of the hemolytic uremic syndrome
Q33358878Infection by Shiga toxin-producing Escherichia coli: an overview
Q36634680Infection by verocytotoxin-producing Escherichia coli
Q37968453Infectious diarrhea. Managing a misery that is still worldwide
Q40978125Infectious gastroenterocolitides in children: an update on emerging pathogens
Q33551086Influence of Escherichia coli shiga toxin on the mammalian central nervous system
Q52605063Influence of RNase E deficiency on the production of stx2-bearing phages and Shiga toxin in an RNase E-inducible strain of enterohaemorrhagic Escherichia coli (EHEC) O157:H7.
Q46437878Influence of acetic, citric, and lactic acids on Escherichia coli O157:H7 membrane lipid composition, verotoxin secretion, and acid resistance in simulated gastric fluid
Q38299550Influence of length and conformation of saccharide head groups on the mechanics of glycolipid membranes: Unraveled by off-specular neutron scattering
Q38359579Influence of phospholipid chain length on verotoxin/globotriaosyl ceramide binding in model membranes: comparison of a supported bilayer film and liposomes
Q33408179Inhibition of water absorption and selective damage to human colonic mucosa are induced by subtilase cytotoxin produced by Escherichia coli O113:H21
Q43810790Inhibitory activity of Bifidobacterium longum HY8001 against Vero cytotoxin of Escherichia coli O157:H7.
Q40592342Interaction of Shiga toxin from Escherichia coli with human intestinal epithelial cell lines and explants: Stx2 induces epithelial damage in organ culture
Q33357114Interleukin-8 and polymorphoneutrophil leucocyte activation in hemolytic uremic syndrome of childhood
Q33768841Invasion of epithelial cells by locus of enterocyte effacement-negative enterohemorrhagic Escherichia coli
Q33953014Investigating the global genomic diversity of Escherichia coli using a multi-genome DNA microarray platform with novel gene prediction strategies
Q40162448Ionic requirements for entry of Shiga toxin from Shigella dysenteriae 1 into cells
Q33337601Is immune cell activation the missing link in the pathogenesis of post-diarrhoeal HUS?
Q37156797Isolation and characterization of monoclonal antibodies to Shiga-like toxin II of enterohemorrhagic Escherichia coli and use of the monoclonal antibodies in a colony enzyme-linked immunosorbent assay
Q33502935Isolation and characterization of sorbitol-fermenting Shiga toxin (Verocytotoxin)-producing Escherichia coli O157:H- strains in the Czech Republic.
Q44776680Isolation and characterization of the Shiga toxin gene (stx)-bearing Escherichia coli O157 and non-O157 from retail meats in Shandong Province, China, and characterization of the O157-derived stx2 phages
Q73208404Isolation and characterization of verocytotoxin-producing Escherichia coli O157 from slaughter pigs and poultry
Q33661058Isolation and characterization of verocytotoxin-producing Escherichia coli O157 strains from Dutch cattle and sheep.
Q33396996Isolation in Italy of a verotoxin-producing strain of Escherichia coli O157:H7 from a child with hemolytic-uraemic syndrome.
Q54774130Isolation of Escherichia coli O157:H7 from dairy cattle associated with two cases of haemolytic uraemic syndrome.
Q33497617Isolation of enterohemorrhagic Escherichia coli O157 strains from patients with hemolytic-uremic syndrome by using immunomagnetic separation, DNA-based methods, and direct culture
Q43054174Isolation of verocytotoxin-producing Escherichia coli from milk filters in south-western Ontario
Q33373368Journey in reverse: TTP from bedside to blood bank to bench
Q38342112Kinetic Analyses of Bindings of Shiga-like Toxin to Clustered and Dispersed Gb3 Glyco-Arrays on a Quartz-Crystal Microbalance
Q40207879Laboratory investigation of outbreak of hemorrhagic colitis caused by Escherichia coli O157:H7.
Q40200226Latex agglutination test for detection of Escherichia coli serotype O157.
Q38305667Lipid modulation of glycolipid receptor function. Availability of Gal(alpha 1-4)Gal disaccharide for verotoxin binding in natural and synthetic glycolipids
Q33497678Lipopolysaccharide-specific antibodies in plasma and stools of children with Shigella-associated leukemoid reaction and hemolytic-uremic syndrome
Q39830255Localization of intravenously administered verocytotoxins (Shiga-like toxins) 1 and 2 in rabbits immunized with homologous and heterologous toxoids and toxin subunits
Q33328565Localization of verotoxin receptors in nervous system.
Q35324691Long term risk for hypertension, renal impairment, and cardiovascular disease after gastroenteritis from drinking water contaminated with Escherichia coli O157:H7: a prospective cohort study
Q35754475Luminescence based enzyme-labeled phage (Phazyme) assays for rapid detection of Shiga toxin producing Escherichia coli serogroups.
Q45855222M-COPA, a novel Golgi system disruptor, suppresses apoptosis induced by Shiga toxin
Q35531436Magnetic resonance imaging and histopathological study of brain lesions in rabbits given intravenous verotoxin 2.
Q33449519Management of hemolytic-uremic syndrome
Q38604123Metapopulation dynamics of Escherichia coli O157 in cattle: an exploratory model
Q33490231Microangiopathic hemolytic anemia and severe thrombocytopenia in Brucella infection
Q54366958Microbead-based immunoassay for simultaneous detection of Shiga toxins and isolation of Escherichia coli O157 in foods.
Q47127903Microvesicle Involvement in Shiga Toxin-Associated Infection
Q43329511Mitigating the antimicrobial activities of selected organic acids and commercial sanitizers with various neutralizing agents
Q71785854Modelling of the interaction of verotoxin-1 (VT1) with its glycolipid receptor, globotriaosylceramide (Gb3)
Q43566476Modelling the epidemiology and transmission of Verocytotoxin-producing Escherichia coli serogroups O26 and O103 in two different calf cohorts
Q40154302Modification of the glycolipid-binding specificity of vero cytotoxin by polymyxin B and other cyclic amphipathic peptides
Q37009028Modulation of the enterohemorrhagic E. coli virulence program through the human gastrointestinal tract
Q58870866Molecular Characterization of Shiga Toxin-ProducingEscherichia coli
Q33378528Molecular analysis as an aid to assess the public health risk of non-O157 Shiga toxin-producing Escherichia coli strains
Q30798461Molecular characterization of the locus encoding biosynthesis of the lipopolysaccharide O antigen of Escherichia coli serotype O113
Q41873961Molecular damage and induction of proinflammatory cytokines in human endothelial cells exposed to Shiga toxin 1, Shiga toxin 2, and alpha-sarcin
Q34041771Molecular profiling and phenotype analysis of Escherichia coli O26:H11 and O26:NM: secular and geographic consistency of enterohemorrhagic and enteropathogenic isolates
Q33502724Monocyte chemoattractant protein-1 and interleukin-8 levels in urine and serum of patents with hemolytic uremic syndrome
Q40815072Morphological and intracellular alterations induced by cytotoxin VT2y produced by Escherichia coli isolated from chickens with swollen head syndrome
Q36986374Mouse model for colonization and disease caused by enterohemorrhagic Escherichia coli O157:H7
Q34497115Mouse models of Escherichia coli O157:H7 infection and shiga toxin injection
Q34005780Mouse toxicity and cytokine release by verotoxin 1 B subunit mutants
Q35551789Murine antibody responses to the verotoxin 1 B subunit: demonstration of major histocompatibility complex dependence and an immunodominant epitope involving phenylalanine 30
Q33490306Myeloproliferative and metabolic causes
Q33489463Myocarditis and haemolytic uraemic syndrome.
Q33338235Nationwide study of haemolytic uraemic syndrome: clinical, microbiological, and epidemiological features.
Q30300135Natural killer T (NKT) cells accelerate Shiga toxin type 2 (Stx2) pathology in mice
Q42973858Nephrology, dialysis and transplantation
Q40203480Neutralization receptor-based immunoassay for detection of neutralizing antibodies to Escherichia coli verocytotoxin 1.
Q38300698Neutralizing activity of polyvalent Gb3, Gb2 and galacto-trehalose models against Shiga toxins
Q39432827Neutralizing antibodies to Escherichia coli Vero cytotoxin 1 and antibodies to O157 lipopolysaccharide in healthy farm family members and urban residents.
Q33965188Neutralizing antibodies to Shiga toxin type 2 (Stx2) reduce colonization of mice by Stx2-expressing Escherichia coli O157:H7.
Q69375699Neutrophil elastases and haemolytic uraemic syndrome
Q30434555New developments in enteric bacterial toxins
Q36539801New immuno-PCR assay for detection of low concentrations of shiga toxin 2 and its variants
Q33409878New insights into Shiga toxin-mediated endothelial dysfunction in hemolytic uremic syndrome
Q33397724New insights into the haemolytic uraemic syndromes
Q43967019Nitric oxide-mediated apoptosis in rat macrophages subjected to Shiga toxin 2 from Escherichia coli
Q43874437Nitrobenzylthioinosine (NBT), a nucleoside transport inhibitor, protects against Shiga toxin cytotoxicity in human microvascular endothelial cells
Q42142131Novel repressor of Escherichia coli O157:H7 motility encoded in the putative fimbrial cluster OI-1.
Q36265701Nucleotide sequence and promoter mapping of the Escherichia coli Shiga-like toxin operon of bacteriophage H-19B.
Q34633814Nucleotide sequence of the Shiga-like toxin genes of Escherichia coli
Q43607603Occurrence of Escherichia coli O157 in Finnish cattle
Q50124787Occurrence of Vibrio and other pathogenic bacteria in Mytilus galloprovincialis (mussels) harvested from Adriatic Sea, Italy
Q42598711Occurrence of subtilase cytotoxin and relation with other virulence factors in verocytotoxigenic Escherichia coli isolated from food and cattle in Argentina
Q33684744Occurrence of verocytotoxin-producing Escherichia coli O157 on Dutch dairy farms
Q34128036One of two copies of the gene for the activatable shiga toxin type 2d in Escherichia coli O91:H21 strain B2F1 is associated with an inducible bacteriophage
Q37643869Oral intoxication of mice with Shiga toxin type 2a (Stx2a) and protection by anti-Stx2a monoclonal antibody 11E10.
Q38674148Ouabain Protects Human Renal Cells against the Cytotoxic Effects of Shiga Toxin Type 2 and Subtilase Cytotoxin
Q33499151Outbreak of Escherichia coli O157:H7 infection in a large family
Q33419782Overview and Historical Perspectives
Q57676134PATHOGENESIS OF HAEMOLYTIC URAEMIC SYNDROME
Q43518801Passive protection of purified yolk immunoglobulin administered against Shiga toxin 1 in mouse models
Q24550740Pathogenesis and diagnosis of Shiga toxin-producing Escherichia coli infections
Q33712512Pathogenesis of Escherichia coli O157:H7 strain 86-24 following oral infection of BALB/c mice with an intact commensal flora
Q33338331Pathogenesis of Shiga toxin-associated hemolytic uremic syndrome.
Q33445806Pathogenesis of the hemolytic uremic syndromes: current concepts
Q41513764Pathogenic Escherichia coli: a new etiology for acute ileitis in children
Q27003178Pathogenicity, host responses and implications for management of enterohemorrhagic Escherichia coli O157:H7 infection
Q33359875Phenotypic and genotypic analyses of enterohemorrhagic Escherichia coli O145 strains from patients in Germany
Q40150192Physicochemical and biological properties of purified Escherichia coli Shiga-like toxin II variant.
Q39825714Polysaccharide side chains are not required for attaching and effacing adhesion of Escherichia coli O157:H7.
Q33388706Post-transplantation outcome of patients with hemolytic-uremic syndrome: update
Q28333178Postpartum haemolytic uraemic syndrome precipitated by antibiotics. Case report
Q67913265Preparation of VT1 and VT2 hybrid toxins from their purified dissociated subunits. Evidence for B subunit modulation of a subunit function
Q34545082Preparation, characterization, and immunological properties in mice of Escherichia coli O157 O-specific polysaccharide-protein conjugate vaccines
Q33331011Pretreatment of mice with lipopolysaccharide (LPS) or IL-1beta exerts dose-dependent opposite effects on Shiga toxin-2 lethality
Q33965946Prevalence and characterization of Shiga toxin-producing Escherichia coli isolated from cattle, food, and children during a one-year prospective study in France
Q34316000Prevalence and virulence factors of Escherichia coli serogroups O26, O103, O111, and O145 shed by cattle in Scotland
Q41883438Prevalence of Escherichia Coli O157:H7 and Enterobacteriaceae on Hands of Workers in Halal Cattle Abattoirs in Peninsular Malaysia
Q36295186Prevalence of Shiga toxin-producing Escherichia coli in beef cattle
Q43197024Prevalence of non-O157:H7 shiga toxin-producing Escherichia coli in diarrheal stool samples from Nebraska
Q35598866Prevalence of shiga toxin-producing Escherichia coli as detected by enzyme-linked immunoassays and real-time PCR during the summer months in northern Alberta, Canada
Q36503463Prevalence of the eaeA gene in verotoxigenic Escherichia coli strains from dairy cattle in Southwest Ontario
Q36505009Prevalence of verocytotoxigenic Escherichia coli in ground beef, pork, and chicken in southwestern Ontario
Q33989285Prevalence, antibiotic susceptibility, and diversity of Escherichia coli O157:H7 isolates from a longitudinal study of beef cattle feedlots
Q43242940Prevention of Escherichia coli O157:H7 infection in gnotobiotic mice associated with Bifidobacterium strains
Q33370606Procalcitonin in children with Escherichia coli O157:H7 associated hemolytic uremic syndrome
Q33387199Production and characterization of a monoclonal antibody specific for enterohemorrhagic Escherichia coli of serotypes O157:H7 and O26:H11.
Q36543571Production and characterization of monoclonal antibodies specific for the lipopolysaccharide of Escherichia coli O157
Q33344261Production and characterization of protective human antibodies against Shiga toxin 1
Q24647895Production of Shiga-like toxin among Escherichia coli strains and other bacteria isolated from diarrhea in São Paulo, Brazil
Q71598028Production of Shiga-like toxins by Escherichia coli O157:H7 can be influenced by the neuroendocrine hormone norepinephrine
Q54442866Production of shiga toxin by a luxS mutant of Escherichia coli O157:H7 in vivo and in vitro.
Q37218835Promoter sequence of Shiga toxin 2 (Stx2) is recognized in vivo, leading to production of biologically active Stx2.
Q33428960Properties of Vero cytotoxin-producing Escherichia coli of human and animal origin belonging to serotypes other than O157:H7
Q36472567Properties of strains of Escherichia coli belonging to serogroup O157 with special reference to production of Vero cytotoxins VT1 and VT2
Q35946861Proteasome inhibitors prevent cell death and prolong survival of mice challenged by Shiga toxin
Q35012362Protection against Shiga toxin 1 challenge by immunization of mice with purified mutant Shiga toxin 1.
Q39824053Protective immunity to Shiga-like toxin I following oral immunization with Shiga-like toxin I B-subunit-producing Vibrio cholerae CVD 103-HgR.
Q64118824Proteomic Analysis of Novel Components of Jellyfish Venom: Deciphering the Mode of Action
Q33414067Purification and characterization of a phage-encoded cytotoxin from an Escherichia coli O111 strain associated with hemolytic-uremic syndrome
Q38360747Purification of Shiga-like toxin 1 by pigeon egg white glycoproteins immobilized on Sepharose gels
Q40200609Purification of an Escherichia coli serogroup O157:H7 verotoxin and its detection in North American hemorrhagic colitis isolates.
Q34545284Purified Shiga-like toxins induce expression of proinflammatory cytokines from murine peritoneal macrophages
Q50093767Putative virulence factors and clonal relationship of O174 Shiga toxin-producing Escherichia coli isolated from human, food and animal sources
Q36226910Quantitative Detection of Shiga Toxins Directly from Stool Specimens of Patients Associated with an Outbreak of Enterohemorrhagic Escherichia coli in Japan--Quantitative Shiga toxin detection from stool during EHEC outbreak
Q37001708Quantitative analysis and partial characterization of cytotoxin production by Salmonella strains
Q73441776RNA aptamers that bind to and inhibit the ribosome-inactivating protein, pepocin
Q30310781Rapid Apoptosis Induced by Shiga Toxin in HeLa Cells
Q41895684Rapid and sensitive method for detection of Shiga-like toxin-producing Escherichia coli in ground beef using the polymerase chain reaction
Q33415662Rapid diagnosis of Streptococcus pneumoniae-induced haemolytic-uraemic syndrome
Q37174239Rapid method to detect shiga toxin and shiga-like toxin I based on binding to globotriosyl ceramide (Gb3), their natural receptor
Q36455874Reactive oxygen molecules, oxidant injury and renal disease
Q33397981Recent advances in understanding the pathogenesis of the hemolytic uremic syndromes
Q33395662Recent progress of Shiga toxin neutralizer for treatment of infections by Shiga toxin-producing Escherichia coli
Q53224717Recombinant Shiga toxin B subunit elicits protection against Shiga toxin via mixed Th type immune response in mice.
Q33345537Recurrent hemolytic uremic syndrome
Q36420818Recycling of Shiga toxin 2 genes in sorbitol-fermenting enterohemorrhagic Escherichia coli O157:NM
Q35673972Reduced Toxicity of Shiga Toxin (Stx) Type 2c in Mice Compared to Stx2d Is Associated with Instability of Stx2c Holotoxin.
Q73407888Reduction of fecal shedding of enterohemorrhagic Escherichia coli O157:H7 in lambs by feeding microbial feed supplement
Q40564019Regulation of proinflammatory cytokine expression by Shiga toxin 1 and/or lipopolysaccharides in the human monocytic cell line THP-1
Q33383019Relationship between Escherichia coli O157:H7 and diabetes mellitus
Q33335748Relationship between susceptibility to hemolytic-uremic syndrome and levels of globotriaosylceramide in human sera
Q45218594Results of a 6-month survey of stool cultures for Escherichia coli O157:H7.
Q36548021Reversed passive latex agglutination assay for detection of toxigenic Corynebacterium diphtheriae
Q48033924Risk factors for infection with verocytotoxigenic Escherichia coli in cattle on Ontario dairy farms
Q33357383Risk factors for poor renal prognosis in children with hemolytic uremic syndrome
Q33396504Risk factors for the progression of Escherichia coli O157:H7 enteritis to hemolytic-uremic syndrome
Q33502574Risk of hemolytic uremic syndrome after sporadic Escherichia coli O157:H7 infection: results of a Canadian collaborative study. Investigators of the Canadian Pediatric Kidney Disease Research Center
Q40160973Role of a 60-megadalton plasmid and Shiga-like toxins in the pathogenesis of infection caused by enterohemorrhagic Escherichia coli O157:H7 in gnotobiotic piglets.
Q34363235Role of iron in regulation of virulence genes
Q33748229Role of tumor necrosis factor alpha in gnotobiotic mice infected with an Escherichia coli O157:H7 strain
Q33404500Role of vascular endothelial growth factor and angiopoietin 1 in renal injury in hemolytic uremic syndrome
Q33403359STEC-HUS, atypical HUS and TTP are all diseases of complement activation
Q40204465Sensitive method for detecting low numbers of verotoxin-producing Escherichia coli in mixed cultures by use of colony sweeps and polymyxin extraction of verotoxin
Q40200136Sensitive receptor-specified enzyme-linked immunosorbent assay for Escherichia coli verocytotoxin
Q39109154Sensitivity of an immunomagnetic-separation-based test for detecting Escherichia coli O26 in bovine feces.
Q33491633Serodiagnosis by passive hemagglutination test and verotoxin enzyme-linked immunosorbent assay of toxin-producing Escherichia coli infections in patients with hemolytic-uremic syndrome.
Q33412829Serodiagnosis using microagglutination assay during the food-poisoning outbreak in Japan caused by consumption of raw beef contaminated with enterohemorrhagic Escherichia coli O111 and O157
Q43558451Serological differences between verocytotoxin 2 and shiga-like toxin II.
Q33395389Serological response of Shiga toxin-producing Escherichia coli type III secreted proteins in sera from vaccinated rabbits, naturally infected cattle, and humans
Q36973479Serological responses to the B subunit of Shiga-like toxin 1 and its peptide fragments indicate that the B subunit is a vaccine candidate to counter action of the toxin
Q37235962Serotype O157:H7 Escherichia coli from bovine and meat sources
Q33426514Serum antibodies to Escherichia coli serotype O157:H7 in patients with hemolytic uremic syndrome
Q35493730Serum antibody responses of cattle following experimental infection with Escherichia coli O157:H7
Q35616704Severe acute diarrhea
Q33364719Severe thrombotic microangiopathy associated with brucellosis: successful treatment with plasmapheresis
Q36713756Shiga Toxin-Producing Escherichia coli in Plateau Pika (Ochotona curzoniae) on the Qinghai-Tibetan Plateau, China
Q40143836Shiga Toxin-Producing Serogroup O91 Escherichia coli Strains Isolated from Food and Environmental Samples
Q37063416Shiga and Shiga-like toxins
Q36669065Shiga toxin 'goes retro' in human primary kidney cells
Q42920438Shiga toxin 1 and ricin A chain bind to human polymorphonuclear leucocytes through a common receptor
Q54454112Shiga toxin activatable by intestinal mucus in Escherichia coli isolated from humans: predictor for a severe clinical outcome.
Q35869756Shiga toxin gene loss and transfer in vitro and in vivo during enterohemorrhagic Escherichia coli O26 infection in humans
Q26850758Shiga toxin interaction with human intestinal epithelium
Q33413792Shiga toxin production and translocation during microaerobic human colonic infection with Shiga toxin-producing E. coli O157:H7 and O104:H4
Q54456633Shiga toxin-1 affects nitric oxide production by human glomerular endothelial and mesangial cells.
Q33363208Shiga toxin-associated hemolytic uremic syndrome: combined cytotoxic effects of shiga toxin and lipopolysaccharide (endotoxin) on human vascular endothelial cells in vitro.
Q33489940Shiga toxin-associated hemolytic uremic syndrome: effect of sodium butyrate on sensitivity of human umbilical vein endothelial cells to Shiga toxin.
Q33389321Shiga toxin-associated hemolytic uremic syndrome: pathophysiology of endothelial dysfunction
Q33384145Shiga toxin-associated hemolytic-uremic syndrome: combined cytotoxic effects of Shiga toxin, interleukin-1 beta, and tumor necrosis factor alpha on human vascular endothelial cells in vitro
Q33599604Shiga toxin-induced tumor necrosis factor alpha expression: requirement for toxin enzymatic activity and monocyte protein kinase C and protein tyrosine kinases
Q30439707Shiga toxin-mediated disease in MyD88-deficient mice infected with Escherichia coli O157:H7.
Q45282761Shiga toxin-producing Escherichia coli in Central Greece: prevalence and virulence genes of O157:H7 and non-O157 in animal feces, vegetables, and humans
Q34000479Shiga toxin-producing Escherichia coli in swine: the public health perspective
Q33342197Shiga toxin-producing Escherichia coli infection and antibodies against Stx2 and Stx1 in household contacts of children with enteropathic hemolytic-uremic syndrome
Q35844728Shiga toxin-producing Escherichia coli serotype O78:H(-) in family, Finland, 2009.
Q33383432Shiga toxin-producing Escherichia coli strains negative for locus of enterocyte effacement
Q33404640Shiga toxins and the pathophysiology of hemolytic uremic syndrome in humans and animals
Q33370181Shiga toxins present in the gut and in the polymorphonuclear leukocytes circulating in the blood of children with hemolytic-uremic syndrome
Q33330360Shiga toxins stimulate secretion of interleukin-8 from intestinal epithelial cells
Q46937282Shiga-like toxin production and connective tissue protein binding of Escherichia coli isolated from a patient with ulcerative colitis
Q27621547Shiga-like toxins are neutralized by tailored multivalent carbohydrate ligands
Q42125743Shiga-like-toxin-producing Escherichia coli in retail meats and cattle in Thailand
Q39822837Signal transduction responses following adhesion of verocytotoxin-producing Escherichia coli
Q56892711Single chain variable fragment antibodies against Shiga toxins isolated from a human antibody phage display library
Q40197674Single primer pair for amplifying segments of distinct Shiga-like-toxin genes by polymerase chain reaction
Q41925990Sorbitol-Fermenting Enterohemorrhagic Escherichia coli O157:H- Isolates from Czech Patients with Novel Plasmid Composition Not Previously Seen in German Isolates
Q40205809Sorbitol-MacConkey medium for detection of Escherichia coli O157:H7 associated with hemorrhagic colitis
Q28743696Specific egg yolk immunoglobulin as a new preventive approach for Shiga-toxin-mediated diseases
Q42705126Specific inhibitory action of anisodamine against a staphylococcal superantigenic toxin, toxic shock syndrome toxin 1 (TSST-1), leading to down-regulation of cytokine production and blocking of TSST-1 toxicity in mice
Q33490963Spectrum of extrarenal involvement in postdiarrheal hemolytic-uremic syndrome
Q33379319Sporadic bloody diarrhoea-associated thrombotic thrombocytopenic purpura-haemolytic uraemic syndrome: an adult and paediatric comparison
Q33334110Staphylococcus aureus bacteremia as a cause of early relapse of thrombotic thrombocytopenic purpura
Q38315562Structural analysis of the interaction between Shiga toxin B subunits and linear polymers bearing clustered globotriose residues.
Q37428553Study on induction of apoptosis on HeLa and Vero cells by recombinant shiga toxin and its subunits.
Q35931886Sub-Lethal Dose of Shiga Toxin 2 from Enterohemorrhagic Escherichia coli Affects Balance and Cerebellar Cytoarchitecture
Q40163784Surface properties of the Vero cytotoxin-producing Escherichia coli O157:H7.
Q46167654Survival of Escherichia coli O157:H7 in traditional African yoghurt fermentation
Q54682708Susceptibility to verotoxin as a function of the cell cycle
Q34002606Syntheses and immunologic properties of Escherichia coli O157 O-specific polysaccharide and Shiga toxin 1 B subunit conjugates in mice.
Q44581071Synthesis of galactose-containing oligosaccharides through superbeads and superbug approaches: substrate recognition along different biosynthetic pathways
Q44588733Target-selective photo-degradation of verotoxin-1 and reduction of its cytotoxicity to Vero cells using porphyrin-globotriose hybrids.
Q28592771Targeted disruption of Gb3/CD77 synthase gene resulted in the complete deletion of globo-series glycosphingolipids and loss of sensitivity to verotoxins
Q36929589Temporal shedding patterns and virulence factors of Escherichia coli serogroups O26, O103, O111, O145, and O157 in a cohort of beef calves and their dams
Q37182771The Accessory Genome of Shiga Toxin-Producing Escherichia coli Defines a Persistent Colonization Type in Cattle
Q33428611The Antibiotic Polymyxin B Impairs the Interactions between Shiga Toxins and Human Neutrophils.
Q92537986The Association of Cell Division Regulated by DicC With the Formation of Viable but Non-culturable Escherichia coli O157:H7
Q38160938The Canadian contribution to the science of verotoxigenic Escherichia coli and associated illnesses: the early years
Q27680604The Crystal Structure of Shiga Toxin Type 2 with Bound Disaccharide Guides the Design of a Heterobifunctional Toxin Inhibitor
Q33378414The Oklahoma Thrombotic Thrombocytopenic Purpura-Hemolytic Uremic Syndrome Registry: the Swiss connection
Q40552744The P blood group system: biochemical, serological, and clinical aspects
Q54502689The Shiga toxin 2 B subunit inhibits net fluid absorption in human colon and elicits fluid accumulation in rat colon loops.
Q24563989The bacterial colicin active against tumor cells in vitro and in vivo is verotoxin 1
Q90042170The bacterial instrument as a promising therapy for colon cancer
Q33504952The detection of Shiga toxins in the kidney of a patient with hemolytic uremic syndrome
Q33420531The efficacy of recombinant human soluble thrombomodulin for the treatment of shiga toxin-associated hemolytic uremic syndrome model mice
Q41215965The emergency department approach to diarrhea
Q33398109The expression of blood group P1 in post-enteropathic haemolytic uraemic syndrome
Q57704288The hemolytic uremic syndrome
Q71041946The hemolytic uremic syndrome
Q33503414The hemolytic uremic syndrome as a complication of adriamycin nephropathy
Q33445781The histopathology of the hemolytic uremic syndrome associated with verocytotoxin-producing Escherichia coli infections.
Q40949783The identification of three biologically relevant globotriaosyl ceramide receptor binding sites on the Verotoxin 1 B subunit
Q38022246The interactions of human neutrophils with shiga toxins and related plant toxins: danger or safety?
Q41812822The isolation rate of Escherichia coli 0157:H7 in Toronto and surrounding communities
Q42856082The mode of action of Shiga toxin on peptide elongation of eukaryotic protein synthesis
Q33376042The pathogenic mechanisms of Shiga toxin and the Shiga-like toxins
Q69395934The pathophysiology of Hirschsprung's-associated enterocolitis: importance of histologic correlates
Q34081045The prevalence of verocytotoxin-producing Escherichia coli and antimicrobial resistance patterns of nonverocytotoxin-producing Escherichia coli and Salmonella in Ontario broiler chickens
Q24623245The risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections
Q33494653The role of Escherichia coli O 157 infections in the classical (enteropathic) haemolytic uraemic syndrome: results of a Central European, multicentre study
Q54648744The role of tyrosine-114 in the enzymatic activity of the Shiga-like toxin I A-chain.
Q35773392The specific activities of Shiga-like toxin type II (SLT-II) and SLT-II-related toxins of enterohemorrhagic Escherichia coli differ when measured by Vero cell cytotoxicity but not by mouse lethality
Q33445858The use of sorbitol-MacConkey agar in conjunction with a specific antiserum for the detection of Vero cytotoxin-producing strains of Escherichia coli O 157.
Q35018603Three years experience of adults admitted to hospital in north-east Scotland with E. coli O157.
Q33374370Thrombotic microangiopathies: an update
Q33389435Thrombotic microangiopathies: multimers, metalloprotease, and beyond
Q35098992Thrombotic microangiopathy in haematopoietic cell transplantation: an update
Q33393240Thrombotic microangiopathy in systemic lupus erythematosus: a cohort study in North Taiwan
Q33399520Thrombotic microangiopathy: current knowledge and outcomes with plasma exchange
Q33339090Thrombotic thrombocytopenic purpura (TTP) and hemolytic uremic syndrome (HUS): the new thinking
Q33369006Thrombotic thrombocytopenic purpura mimicking acute small bowel Crohn's disease
Q33354806Thrombotic thrombocytopenic purpura: outcome in 24 patients with renal impairment treated with plasma exchange. Canadian Apheresis Study Group
Q43675858Tolerance to lipopolysaccharide (LPS) regulates the endotoxin effects on Shiga toxin-2 lethality
Q39829974Toxicity and immunogenicity of a verotoxin 1 mutant with reduced globotriaosylceramide receptor binding in rabbits.
Q33719947Transcriptional analysis of genes encoding Shiga toxin 2 and its variants in Escherichia coli
Q36375176Transfer region of pO113 from enterohemorrhagic Escherichia coli: similarity with R64 and identification of a novel plasmid-encoded autotransporter, EpeA
Q35512892Translocation of Shiga toxin across polarized intestinal cells in tissue culture
Q33380757Treatment and outcome of Shiga-toxin-associated hemolytic uremic syndrome (HUS).
Q33499711Treatment of plasma refractory thrombotic thrombocytopenic purpura with protein A immunoabsorption
Q69870583Two distinct toxins active on Vero cells from Escherichia coli O157
Q24646436Two toxin-converting phages from Escherichia coli O157:H7 strain 933 encode antigenically distinct toxins with similar biologic activities
Q34002950Typing of intimin genes in human and animal enterohemorrhagic and enteropathogenic Escherichia coli: characterization of a new intimin variant
Q37322141Update on hemolytic uremic syndrome: Diagnostic and therapeutic recommendations
Q37224766Use of a Chinese hamster ovary cell cytotoxicity assay for the rapid diagnosis of pertussis
Q58590838Use of camel single-domain antibodies for the diagnosis and treatment of zoonotic diseases
Q87408599Use of clustered regularly interspaced short palindromic repeat sequence polymorphisms for specific detection of enterohemorrhagic Escherichia coli strains of serotypes O26:H11, O45:H2, O103:H2, O111:H8, O121:H19, O145:H28, and O157:H7 by real-time
Q39821292Use of heme and hemoglobin by Escherichia coli O157 and other Shiga-like-toxin-producing E. coli serogroups
Q36543530Use of the flagellar H7 gene as a target in multiplex PCR assays and improved specificity in identification of enterohemorrhagic Escherichia coli strains
Q28610949Utility of Whole-Genome Sequencing of Escherichia coli O157 for Outbreak Detection and Epidemiological Surveillance
Q35461166Vaccination with genetically modified Shiga-like toxin IIe prevents edema disease in swine
Q38526159Vascular ultrastructure and DNA fragmentation in swine infected with Shiga toxin-producing Escherichia coli
Q33398393Vero cytotoxin-producing strains of Escherichia coli in children with haemolytic uraemic syndrome and diarrhoea in Czechoslovakia
Q37467549Verocytotoxin-producing Escherichia coli (VTEC).
Q59256479Verocytotoxin-producing Escherichia coli in foodstuffs of animal origin
Q33497037Verocytotoxin-producing Escherichia coli infection in hemolytic uremic syndrome in part of western Europe.
Q33721614Verocytotoxins (Shiga-like toxins) produced by Escherichia coli: a minireview of their classification, clinical presentations and management of a heterogeneous family of cytotoxins
Q33391604Verotoxigenic (enterohaemorrhagic) Escherichia coli in infants and toddlers in Czechoslovakia
Q36170601Verotoxigenic Escherichia coli (VTEC): a major public health threat in Canada
Q91975349Verotoxin Receptor-Based Pathology and Therapies
Q33383004Verotoxin biology: molecular events in vascular endothelial injury
Q36752008Verotoxin induces hemorrhagic lesions in rat small intestine. Temporal alteration of vasoactive substances
Q39488477Verotoxin-producing Escherichia coli (VTEC) infection in randomly selected population of Ilam Province (Iran).
Q33427915Verotoxin-producing Escherichia coli infections in Sheffield: cattle as a possible source
Q42164073Verotoxins in bovine and meat verotoxin-producing Escherichia coli isolates: type, number of variants, and relationship to cytotoxicity.
Q40979852Verotoxins inhibit the growth of and induce apoptosis in human astrocytoma cells
Q42120585Virulence Characterization of Shiga-Toxigenic Escherichia coli Isolates from Wholesale Produce
Q93006047Virulence Profiling and Molecular Typing of Shiga Toxin-Producing E. coli (STEC) from Human Sources in Brazil
Q33608157Virulence of enterohemorrhagic Escherichia coli O91:H21 clinical isolates in an orally infected mouse model
Q46797072Yersinia and haemolytic uraemic syndrome
Q74167972[Verotoxin-producing Escherichia coli infections: study of its prevalence in children in the Auvergne region]
Q33369655stx2vha is the dominant genotype of Shiga toxin-producing Escherichia coli O157:H7 isolated from patients and domestic animals in three regions of China
Q33394292von Willebrand factor in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome

Search more.